Updates in the Treatment of Vitiligo

David Rosmarin, MD, provides insights on vitiligo and its prevalence among the patient population.

David Rosmarin, MD, illustrates the impacts of vitiligo on patient quality of life.

Dr Rosmarin gives a brief overview of treatment pathways.

Dr Rosmarin explores several treatment approaches for vitiligo, including specific options for oral repigmentation treatments.

JAK inhibitors’ effectiveness as a frontline treatment option for vitiligo is discussed by a key opinion leader in vitiligo treatment.

Dr Rosmarin describes the impacts of ruxolitinib on the treatment strategies for vitiligo.

Payer perspectives are considered for the treatment of vitiligo.

Dr Rosmarin navigates unmet needs and the trajectory of vitiligo treatment.